These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31556466)

  • 1. ATP1B3 cooperates with BST-2 to promote hepatitis B virus restriction.
    Zheng B; Zhang J; Zheng T; Wang H; Li Z; Huan C; Ning S; Wang Y; Zhang W
    J Med Virol; 2020 Feb; 92(2):201-209. PubMed ID: 31556466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP1B3 Protein Modulates the Restriction of HIV-1 Production and Nuclear Factor κ Light Chain Enhancer of Activated B Cells (NF-κB) Activation by BST-2.
    Nishitsuji H; Sugiyama R; Abe M; Takaku H
    J Biol Chem; 2016 Feb; 291(9):4754-62. PubMed ID: 26694617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopetrosis-Associated Transmembrane Protein 1 Recruits RNA Exosome To Restrict Hepatitis B Virus Replication.
    Ma C; Xu W; Yang Q; Liu W; Xiang Q; Chen J; Zhang Q; Liu Y; Wu K; Wu J
    J Virol; 2020 May; 94(11):. PubMed ID: 32188736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
    Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP1B3 Restricts Hepatitis B Virus Replication Via Reducing the Expression of the Envelope Proteins.
    Zhang J; Zheng T; Zhou X; Wang H; Li Z; Huan C; Zheng B; Zhang W
    Virol Sin; 2021 Aug; 36(4):678-691. PubMed ID: 33534085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the cytoplasmic DNA sensor DAI on replication of hepatitis B virus].
    Wang Q; Li S; Huang H; Liu S; Yang Y; Yang D
    Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):934-8. PubMed ID: 26739467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of tumor necrosis factor-alpha in the anti-HBV activity of tetracycline].
    Ni Y; Jiang F; Xu H; Zeng T; Lei Y; Chen Y; Zhou Z; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):213-8. PubMed ID: 24824125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
    Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
    Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
    Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
    Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
    J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
    Hu K; Huang Y; Mu J; Cheng Z; Zhu X
    Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
    Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
    Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of HBV and its antigens on the expressions of JAK-STAT signal transduction pathway molecules and antiviral proteins of IFN alpha].
    Guan SH; Yang K; Lu MJ; Lu YP; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):440-4. PubMed ID: 22053375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15.
    Zhao ZF; Yang H; Han DW; Zhao LF; Zhang GY; Zhang Y; Liu MS
    World J Gastroenterol; 2006 Oct; 12(37):6046-9. PubMed ID: 17009407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HBV activity and mechanism of marine-derived polyguluronate sulfate (PGS) in vitro.
    Wu L; Wang W; Zhang X; Zhao X; Yu G
    Carbohydr Polym; 2016 Jun; 143():139-48. PubMed ID: 27083353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line.
    Wang B; Zhao XP; Fan YC; Zhang JJ; Zhao J; Wang K
    Antiviral Res; 2013 Mar; 97(3):285-92. PubMed ID: 23274784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-200c targets nuclear factor IA to suppress HBV replication and gene expression via repressing HBV Enhancer I activity.
    Tian H; He Z
    Biomed Pharmacother; 2018 Mar; 99():774-780. PubMed ID: 29710475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation.
    Lv M; Zhang B; Shi Y; Han Z; Zhang Y; Zhou Y; Zhang W; Niu J; Yu XF
    Sci Rep; 2015 Jun; 5():11736. PubMed ID: 26119070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
    Dai XQ; Cai WT; Wu X; Chen Y; Han FM
    Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.